https://www.business-standard.com/article/companies/bharat-biotech-to-begin-trials-of-intranasal-vaccine-for-covid-in-feb-mar-121010800340_1.html
The Phase-1 trials will be conducted in Saint Louis University’s Vaccine and Treatment Evaluation Unit
Bharat Biotech to begin trials of intranasal vaccine for Covid in Feb-Mar
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- US stocks slide after historic Wednesday rally, NASDAQ down 5.7% on Thursday
- Fed’s Goolsbee: A tariff is like a stagflationary shock, challenging for Fed
- Fed’s Bowman: Tariff impact remains unclear
- EUR/USD Price Analysis: Euro surges near 2025 highs as bullish structure strengthens
- President Trump increases tariffs on China to 145%
- The S&P 500 is plunging after having its 10th-best day ever. How to navigate volatility.
- Corona beer parent sees Hispanic consumers cutting back on spending, social gathering
- Investors show up for 30-year Treasury bond auction despite tariff-driven volatility
- Trump retreats but still puts U.S. tariff rate at its highest level in a century. Here’s what it means for prices for clothes, food and more.
- The stock market looks dangerous now — but is it oversold? Watch these signs.
More from UncategorizedMore posts in Uncategorized »
- US stocks slide after historic Wednesday rally, NASDAQ down 5.7% on Thursday
- Fed’s Goolsbee: A tariff is like a stagflationary shock, challenging for Fed
- Fed’s Bowman: Tariff impact remains unclear
- EUR/USD Price Analysis: Euro surges near 2025 highs as bullish structure strengthens
- President Trump increases tariffs on China to 145%
- The S&P 500 is plunging after having its 10th-best day ever. How to navigate volatility.
- Corona beer parent sees Hispanic consumers cutting back on spending, social gathering
- Investors show up for 30-year Treasury bond auction despite tariff-driven volatility
- Trump retreats but still puts U.S. tariff rate at its highest level in a century. Here’s what it means for prices for clothes, food and more.
- The stock market looks dangerous now — but is it oversold? Watch these signs.